Oncology Clinical Research Nurse

Mckesson Corporation; Nashville (TN); On-site; USD 75,000 - 95,000; Full time

Job summary

Sarah Cannon Research Institute (SCRI), part of McKesson, seeks a Clinic Research Nurse to monitor study subjects and ensure protocol compliance throughout treatment. The role requires an RN license, oncology experience, and knowledge of FDA CFRs and GCP.

The successful candidate will manage documentation, coordinate procedures, and work within a team to protect patient safety while advancing oncology trials.

Qualifications

• Associate degree; preferably a bachelor’s degree
• RN License
• Knowledge of medical and research terminology
• Knowledge of FDA CFRs and GCP
• Knowledge of the clinical research processes
• At least 1 year of oncology experience preferred
• At least 1 year of experience in a research setting preferred
• Research Certification (ACRP or CCRP) preferred

Responsibilities

• Follow study subjects to ensure protocol compliance and close monitoring
• Use protocol as the tool to screen, treat, and follow patients
• Ensure patient documentation is completed at each clinic visit while screening
• Ensure medications are approved by the registrar before initiating treatment or changing regimens
• Accurately calculate and document BSA, creatinine clearance, and other protocol conversions
• Schedule follow-up appointments, scans, or related procedures per protocol
• Inform SCRI and clinic personnel when a patient comes off study

Skills

RN experience

Oncology experience

Medical terminology

Regulatory knowledge

Protocol adherence

CRF documentation

Education

Associate degree; preferably Bachelor's

Job description

Sarah Cannon Research Institute (SCRI), part of McKesson, seeks a Clinic Research Nurse to monitor study subjects and ensure protocol compliance throughout treatment. The role requires an RN license, oncology experience, and knowledge of FDA CFRs and GCP.

The successful candidate will manage documentation, coordinate procedures, and work within a team to protect patient safety while advancing oncology trials.